

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97284851 |
| 2 | protein localization to endosome (GO:0036010) | 4.38233641 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 3.96912174 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 3.96912174 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.82045505 |
| 6 | pinocytosis (GO:0006907) | 3.79531155 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.66023732 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 3.62894841 |
| 9 | synaptic vesicle maturation (GO:0016188) | 3.61779015 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.50611597 |
| 11 | skin morphogenesis (GO:0043589) | 3.48622327 |
| 12 | locomotory exploration behavior (GO:0035641) | 3.48103720 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.46887792 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37833548 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37833548 |
| 16 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.29428033 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29055831 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.27755051 |
| 19 | hypotonic response (GO:0006971) | 3.27264962 |
| 20 | barbed-end actin filament capping (GO:0051016) | 3.15498315 |
| 21 | cell-substrate junction assembly (GO:0007044) | 3.14912237 |
| 22 | negative T cell selection (GO:0043383) | 3.12407671 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 3.04749781 |
| 24 | cellular response to zinc ion (GO:0071294) | 3.04108280 |
| 25 | regulation of early endosome to late endosome transport (GO:2000641) | 3.03314465 |
| 26 | actin nucleation (GO:0045010) | 3.00692212 |
| 27 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.00528866 |
| 28 | membrane raft organization (GO:0031579) | 2.97079989 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92272003 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91847718 |
| 31 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.89312178 |
| 32 | adherens junction assembly (GO:0034333) | 2.88245201 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87957043 |
| 34 | negative regulation of cell killing (GO:0031342) | 2.87957043 |
| 35 | focal adhesion assembly (GO:0048041) | 2.87031157 |
| 36 | cell-substrate adherens junction assembly (GO:0007045) | 2.87031157 |
| 37 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.86239069 |
| 38 | response to laminar fluid shear stress (GO:0034616) | 2.84583825 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.83733623 |
| 40 | signal complex assembly (GO:0007172) | 2.82932056 |
| 41 | platelet aggregation (GO:0070527) | 2.81367730 |
| 42 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.80223033 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 2.79748180 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 2.78296655 |
| 45 | endodermal cell differentiation (GO:0035987) | 2.74831667 |
| 46 | vocalization behavior (GO:0071625) | 2.70353880 |
| 47 | leukocyte aggregation (GO:0070486) | 2.70142453 |
| 48 | regulation of integrin activation (GO:0033623) | 2.69540816 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.69056963 |
| 50 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69011312 |
| 51 | cell adhesion mediated by integrin (GO:0033627) | 2.66730134 |
| 52 | basement membrane organization (GO:0071711) | 2.65200903 |
| 53 | positive regulation of receptor recycling (GO:0001921) | 2.64982795 |
| 54 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63930540 |
| 55 | modulation by symbiont of host defense response (GO:0052031) | 2.63930540 |
| 56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63930540 |
| 57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63930540 |
| 58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63930540 |
| 59 | modulation by symbiont of host immune response (GO:0052553) | 2.63930540 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 2.63771919 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 2.62796958 |
| 62 | sequestering of actin monomers (GO:0042989) | 2.62611990 |
| 63 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.62333067 |
| 64 | epithelial cell-cell adhesion (GO:0090136) | 2.62077117 |
| 65 | embryonic process involved in female pregnancy (GO:0060136) | 2.61643865 |
| 66 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.61431005 |
| 67 | modulation by symbiont of host cellular process (GO:0044068) | 2.61410270 |
| 68 | neutrophil activation (GO:0042119) | 2.60967200 |
| 69 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.60594853 |
| 70 | hyaluronan catabolic process (GO:0030214) | 2.59514057 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 2.58830480 |
| 72 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.56829984 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.56512239 |
| 74 | granulocyte activation (GO:0036230) | 2.55519873 |
| 75 | cortical actin cytoskeleton organization (GO:0030866) | 2.54595661 |
| 76 | actin filament capping (GO:0051693) | 2.53825819 |
| 77 | hemidesmosome assembly (GO:0031581) | 2.52767575 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.52142871 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 2.51811476 |
| 80 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51654080 |
| 81 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.51320691 |
| 82 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.51161268 |
| 83 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.50782075 |
| 84 | mannose metabolic process (GO:0006013) | 2.50354326 |
| 85 | pentose-phosphate shunt (GO:0006098) | 2.49627402 |
| 86 | stress fiber assembly (GO:0043149) | 2.49155304 |
| 87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.49081210 |
| 88 | thymic T cell selection (GO:0045061) | 2.48527624 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 2.48316168 |
| 90 | sodium ion export (GO:0071436) | 2.47325195 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 2.47212829 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.47002204 |
| 93 | substrate-dependent cell migration (GO:0006929) | 2.45439334 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 2.45077235 |
| 95 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.44604365 |
| 96 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.44426104 |
| 97 | T cell selection (GO:0045058) | 2.44303224 |
| 98 | positive regulation of lamellipodium assembly (GO:0010592) | 2.43465024 |
| 99 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.43277128 |
| 100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.42797435 |
| 101 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.42392725 |
| 102 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.41805908 |
| 103 | exploration behavior (GO:0035640) | 2.41804191 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.41683956 |
| 105 | leukocyte cell-cell adhesion (GO:0007159) | 2.41486385 |
| 106 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.40243098 |
| 107 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.39538853 |
| 108 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.39538853 |
| 109 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.39538853 |
| 110 | mast cell activation (GO:0045576) | 2.38999669 |
| 111 | protein retention in ER lumen (GO:0006621) | 2.38965915 |
| 112 | negative regulation of actin filament polymerization (GO:0030837) | 2.38317242 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37884946 |
| 114 | angiogenesis involved in wound healing (GO:0060055) | 2.37078890 |
| 115 | membrane protein ectodomain proteolysis (GO:0006509) | 2.36998140 |
| 116 | homotypic cell-cell adhesion (GO:0034109) | 2.35956509 |
| 117 | positive regulation of lamellipodium organization (GO:1902745) | 2.35952272 |
| 118 | natural killer cell differentiation (GO:0001779) | 2.35646173 |
| 119 | wound healing, spreading of epidermal cells (GO:0035313) | 2.35447147 |
| 120 | response to muramyl dipeptide (GO:0032495) | 2.35330226 |
| 121 | myeloid dendritic cell activation (GO:0001773) | 2.35259147 |
| 122 | neuromuscular process controlling balance (GO:0050885) | 2.35227945 |
| 123 | response to interleukin-15 (GO:0070672) | 2.35226577 |
| 124 | wound healing, spreading of cells (GO:0044319) | 2.34391128 |
| 125 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.33816377 |
| 126 | positive regulation of axon extension (GO:0045773) | 2.33693317 |
| 127 | regulation of antigen processing and presentation (GO:0002577) | 2.33027777 |
| 128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.31711237 |
| 129 | fibril organization (GO:0097435) | 2.31492507 |
| 130 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.30350045 |
| 131 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.28250818 |
| 132 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28196036 |
| 133 | dendritic cell differentiation (GO:0097028) | 2.27855642 |
| 134 | heterotypic cell-cell adhesion (GO:0034113) | 2.27445082 |
| 135 | negative regulation of stress fiber assembly (GO:0051497) | 2.25000694 |
| 136 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.24126382 |
| 137 | natural killer cell mediated immunity (GO:0002228) | 2.24032404 |
| 138 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.24032404 |
| 139 | regulation of ARF GTPase activity (GO:0032312) | 2.23694312 |
| 140 | regulation of leukocyte degranulation (GO:0043300) | 2.23532257 |
| 141 | cellular response to interferon-alpha (GO:0035457) | 2.22878345 |
| 142 | positive regulation of macrophage differentiation (GO:0045651) | 2.22465378 |
| 143 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22407797 |
| 144 | detection of other organism (GO:0098543) | 2.22093293 |
| 145 | regulation of defense response to virus by virus (GO:0050690) | 2.22009117 |
| 146 | actin filament bundle assembly (GO:0051017) | 2.21414550 |
| 147 | actin filament bundle organization (GO:0061572) | 2.21414550 |
| 148 | negative regulation of anoikis (GO:2000811) | 2.21377553 |
| 149 | protein maturation by protein folding (GO:0022417) | 2.21060713 |
| 150 | response to peptidoglycan (GO:0032494) | 2.20733695 |
| 151 | positive regulation of fibroblast migration (GO:0010763) | 2.20692821 |
| 152 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.20692208 |
| 153 | apoptotic cell clearance (GO:0043277) | 2.20555409 |
| 154 | cortical cytoskeleton organization (GO:0030865) | 2.19966405 |
| 155 | negative regulation of interleukin-12 production (GO:0032695) | 2.19442273 |
| 156 | positive thymic T cell selection (GO:0045059) | 2.19332897 |
| 157 | integrin-mediated signaling pathway (GO:0007229) | 2.18225447 |
| 158 | actin filament depolymerization (GO:0030042) | 2.17856998 |
| 159 | endocytic recycling (GO:0032456) | 2.17748404 |
| 160 | leukocyte degranulation (GO:0043299) | 2.16921746 |
| 161 | hepatocyte apoptotic process (GO:0097284) | 2.16116209 |
| 162 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.15409178 |
| 163 | regulation of necroptotic process (GO:0060544) | 2.14168018 |
| 164 | mesodermal cell differentiation (GO:0048333) | 2.13762433 |
| 165 | negative regulation of fatty acid transport (GO:2000192) | 2.13680671 |
| 166 | adhesion of symbiont to host cell (GO:0044650) | 2.12580642 |
| 167 | virion attachment to host cell (GO:0019062) | 2.12580642 |
| 168 | detection of bacterium (GO:0016045) | 2.11679769 |
| 169 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.11077446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.96549095 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.93336101 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.87422134 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.79155303 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.76892247 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.76639531 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.91057589 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60565454 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57714428 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51922112 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43626306 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.40929497 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40630236 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.37403644 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.37301931 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.33225094 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30814421 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20941980 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.04150823 |
| 20 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03588161 |
| 21 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02648044 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97290600 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96672079 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93793374 |
| 25 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88106413 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87770512 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.87518708 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85043218 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76863380 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76645320 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76577538 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75777527 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73492456 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.70511161 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70267713 |
| 36 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68034876 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.67872333 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.67718042 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64685164 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63889652 |
| 41 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63725068 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57916927 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53803948 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53297181 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52928024 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51503180 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50426975 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49049016 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48437452 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47794180 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47509971 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46865951 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45548804 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45328967 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44043273 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41932527 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40497163 |
| 58 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39100508 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38693058 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35739929 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31019313 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30769147 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30423689 |
| 64 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29818414 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29818414 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29718477 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29661712 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28383037 |
| 69 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27772836 |
| 70 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26862723 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26614898 |
| 72 | * MYB_26560356_Chip-Seq_TH1_Human | 1.25831950 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25394356 |
| 74 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24500418 |
| 75 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24264650 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24213028 |
| 77 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23822598 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21774670 |
| 79 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21763543 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18275007 |
| 81 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18225192 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17891744 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17641043 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17110182 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16658020 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15819679 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15521118 |
| 88 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.14864290 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14759343 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.14696787 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13309798 |
| 92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13296546 |
| 93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12582565 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11897757 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11233399 |
| 96 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.10095079 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09388835 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09249190 |
| 99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09095265 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08748358 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07951995 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07836436 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07733199 |
| 104 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06589395 |
| 105 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05976836 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05877689 |
| 107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05074872 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04315581 |
| 109 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03232725 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03159893 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02661308 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02278430 |
| 113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01753857 |
| 114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00870284 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00595760 |
| 116 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00145570 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00142218 |
| 118 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99110027 |
| 119 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99054991 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98710766 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97537364 |
| 122 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96760311 |
| 123 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96494112 |
| 124 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95021200 |
| 125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93194055 |
| 126 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92661279 |
| 127 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90555493 |
| 128 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90003351 |
| 129 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89995106 |
| 130 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88380445 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87413102 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87153225 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86317143 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85878126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.23534532 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.21877798 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.00287907 |
| 4 | MP0004510_myositis | 2.75071636 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.70977373 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.55607265 |
| 7 | MP0003303_peritoneal_inflammation | 2.46508759 |
| 8 | MP0003436_decreased_susceptibility_to | 2.39981794 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.31933861 |
| 10 | MP0000685_abnormal_immune_system | 2.28990842 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.28833141 |
| 12 | MP0005451_abnormal_body_composition | 2.17229244 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.16849613 |
| 14 | MP0003091_abnormal_cell_migration | 2.14724128 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.14242925 |
| 16 | MP0009785_altered_susceptibility_to | 2.13459832 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.13415753 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.06970397 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.05261921 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.04569248 |
| 21 | * MP0002419_abnormal_innate_immunity | 2.00388320 |
| 22 | MP0005671_abnormal_response_to | 1.98401436 |
| 23 | MP0003279_aneurysm | 1.96836072 |
| 24 | MP0009840_abnormal_foam_cell | 1.96270273 |
| 25 | * MP0002452_abnormal_antigen_presenting | 1.95138693 |
| 26 | MP0003075_altered_response_to | 1.91416995 |
| 27 | MP0005387_immune_system_phenotype | 1.87756672 |
| 28 | MP0001790_abnormal_immune_system | 1.87756672 |
| 29 | MP0001958_emphysema | 1.85451727 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.78928027 |
| 31 | MP0001800_abnormal_humoral_immune | 1.78773205 |
| 32 | MP0008260_abnormal_autophagy | 1.77634394 |
| 33 | * MP0001819_abnormal_immune_cell | 1.74964276 |
| 34 | * MP0002420_abnormal_adaptive_immunity | 1.74810888 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.72002026 |
| 36 | MP0003879_abnormal_hair_cell | 1.71733376 |
| 37 | MP0002723_abnormal_immune_serum | 1.69481486 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.64781895 |
| 39 | MP0005025_abnormal_response_to | 1.63922141 |
| 40 | MP0002006_tumorigenesis | 1.63875415 |
| 41 | MP0004858_abnormal_nervous_system | 1.63551968 |
| 42 | MP0003045_fibrosis | 1.62969372 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.62556589 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.56743864 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.54120961 |
| 46 | MP0001348_abnormal_lacrimal_gland | 1.53029754 |
| 47 | MP0010307_abnormal_tumor_latency | 1.50930380 |
| 48 | MP0003448_altered_tumor_morphology | 1.50509713 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.48439278 |
| 50 | * MP0004947_skin_inflammation | 1.47758910 |
| 51 | MP0002405_respiratory_system_inflammati | 1.46927600 |
| 52 | MP0000858_altered_metastatic_potential | 1.46306408 |
| 53 | MP0000604_amyloidosis | 1.40246834 |
| 54 | MP0005023_abnormal_wound_healing | 1.40187647 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.39117465 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.38520688 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.38192552 |
| 58 | * MP0002398_abnormal_bone_marrow | 1.35546300 |
| 59 | MP0006082_CNS_inflammation | 1.34910968 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.32295957 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.29597375 |
| 62 | MP0005310_abnormal_salivary_gland | 1.27144795 |
| 63 | * MP0000716_abnormal_immune_system | 1.26429214 |
| 64 | MP0002060_abnormal_skin_morphology | 1.25099557 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.22988685 |
| 66 | MP0005166_decreased_susceptibility_to | 1.22077298 |
| 67 | MP0006054_spinal_hemorrhage | 1.22046980 |
| 68 | MP0001542_abnormal_bone_strength | 1.20220440 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.20046087 |
| 70 | MP0005275_abnormal_skin_tensile | 1.19830696 |
| 71 | MP0003635_abnormal_synaptic_transmissio | 1.19696767 |
| 72 | MP0000343_altered_response_to | 1.14346721 |
| 73 | MP0000013_abnormal_adipose_tissue | 1.14180302 |
| 74 | * MP0002998_abnormal_bone_remodeling | 1.12432716 |
| 75 | MP0002796_impaired_skin_barrier | 1.09228309 |
| 76 | * MP0001845_abnormal_inflammatory_respons | 1.08733354 |
| 77 | MP0002933_joint_inflammation | 1.07390675 |
| 78 | MP0008004_abnormal_stomach_pH | 1.06534364 |
| 79 | MP0008961_abnormal_basal_metabolism | 1.06097862 |
| 80 | MP0000490_abnormal_crypts_of | 1.05797682 |
| 81 | MP0001915_intracranial_hemorrhage | 1.04731106 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.04386987 |
| 83 | * MP0001849_ear_inflammation | 1.02816489 |
| 84 | MP0005165_increased_susceptibility_to | 1.02007224 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 1.00225481 |
| 86 | MP0001545_abnormal_hematopoietic_system | 1.00225481 |
| 87 | MP0000767_abnormal_smooth_muscle | 1.00114372 |
| 88 | MP0003329_amyloid_beta_deposits | 0.98687200 |
| 89 | MP0004270_analgesia | 0.97699885 |
| 90 | * MP0002429_abnormal_blood_cell | 0.97245084 |
| 91 | MP0005621_abnormal_cell_physiology | 0.97051699 |
| 92 | MP0009046_muscle_twitch | 0.96770216 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.95752016 |
| 94 | MP0004233_abnormal_muscle_weight | 0.95356500 |
| 95 | MP0002722_abnormal_immune_system | 0.94229443 |
| 96 | MP0001851_eye_inflammation | 0.93886237 |
| 97 | MP0005501_abnormal_skin_physiology | 0.93721201 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.93696730 |
| 99 | MP0001243_abnormal_dermal_layer | 0.93282896 |
| 100 | MP0003828_pulmonary_edema | 0.91650422 |
| 101 | MP0005409_darkened_coat_color | 0.90871809 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.90498981 |
| 103 | MP0004811_abnormal_neuron_physiology | 0.89189727 |
| 104 | MP0002063_abnormal_learning/memory/cond | 0.88650425 |
| 105 | MP0002254_reproductive_system_inflammat | 0.87220172 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.84955527 |
| 107 | MP0003724_increased_susceptibility_to | 0.84871039 |
| 108 | MP0009333_abnormal_splenocyte_physiolog | 0.83209151 |
| 109 | MP0009745_abnormal_behavioral_response | 0.82940425 |
| 110 | MP0000733_abnormal_muscle_development | 0.82691929 |
| 111 | * MP0003795_abnormal_bone_structure | 0.81503998 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.79289163 |
| 113 | MP0009278_abnormal_bone_marrow | 0.78844393 |
| 114 | MP0005164_abnormal_response_to | 0.78790702 |
| 115 | MP0003941_abnormal_skin_development | 0.77807950 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.77051462 |
| 117 | MP0000703_abnormal_thymus_morphology | 0.76959244 |
| 118 | MP0000249_abnormal_blood_vessel | 0.76820934 |
| 119 | MP0001881_abnormal_mammary_gland | 0.75301817 |
| 120 | MP0001853_heart_inflammation | 0.74917646 |
| 121 | MP0005390_skeleton_phenotype | 0.74915714 |
| 122 | MP0004883_abnormal_blood_vessel | 0.74641529 |
| 123 | * MP0001216_abnormal_epidermal_layer | 0.74227294 |
| 124 | MP0002064_seizures | 0.73411102 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.71460017 |
| 126 | MP0003283_abnormal_digestive_organ | 0.71238451 |
| 127 | MP0008874_decreased_physiological_sensi | 0.70464836 |
| 128 | MP0008469_abnormal_protein_level | 0.69956515 |
| 129 | MP0000371_diluted_coat_color | 0.68129258 |
| 130 | MP0004272_abnormal_basement_membrane | 0.67735229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.83299360 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.67709990 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.67410619 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.07710081 |
| 5 | Dilatation of the ascending aorta (HP:0005111) | 2.94719241 |
| 6 | Absent frontal sinuses (HP:0002688) | 2.92458111 |
| 7 | Aortic aneurysm (HP:0004942) | 2.89911773 |
| 8 | Frequent falls (HP:0002359) | 2.84404731 |
| 9 | Protrusio acetabuli (HP:0003179) | 2.80149663 |
| 10 | Cellulitis (HP:0100658) | 2.79049911 |
| 11 | Premature rupture of membranes (HP:0001788) | 2.77229290 |
| 12 | Apathy (HP:0000741) | 2.76260664 |
| 13 | Diminished motivation (HP:0000745) | 2.75983562 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74830848 |
| 15 | Lower limb amyotrophy (HP:0007210) | 2.68731473 |
| 16 | Myositis (HP:0100614) | 2.65306956 |
| 17 | Ankle contracture (HP:0006466) | 2.64716608 |
| 18 | Abnormal platelet volume (HP:0011876) | 2.62460079 |
| 19 | Aortic dissection (HP:0002647) | 2.60081128 |
| 20 | Vascular tortuosity (HP:0004948) | 2.58286212 |
| 21 | Arterial tortuosity (HP:0005116) | 2.55062652 |
| 22 | Increased mean platelet volume (HP:0011877) | 2.54825761 |
| 23 | Distal lower limb muscle weakness (HP:0009053) | 2.54631251 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 2.51547096 |
| 25 | Spinal rigidity (HP:0003306) | 2.51542097 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 2.47357884 |
| 27 | Myocardial infarction (HP:0001658) | 2.45629954 |
| 28 | Distal upper limb amyotrophy (HP:0007149) | 2.44831175 |
| 29 | Upper limb amyotrophy (HP:0009129) | 2.44831175 |
| 30 | Fragile skin (HP:0001030) | 2.40779274 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.38757997 |
| 32 | Peritonitis (HP:0002586) | 2.38436547 |
| 33 | Hematochezia (HP:0002573) | 2.36492952 |
| 34 | Short nail (HP:0001799) | 2.36070436 |
| 35 | Increased density of long bones (HP:0006392) | 2.35966439 |
| 36 | Achilles tendon contracture (HP:0001771) | 2.35351335 |
| 37 | Spinal muscular atrophy (HP:0007269) | 2.35232292 |
| 38 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.33349038 |
| 39 | Hand muscle atrophy (HP:0009130) | 2.33144885 |
| 40 | Polygenic inheritance (HP:0010982) | 2.32819713 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.31953358 |
| 42 | Recurrent fungal infections (HP:0002841) | 2.31785734 |
| 43 | Cervical subluxation (HP:0003308) | 2.31554618 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 2.30627520 |
| 45 | Blue sclerae (HP:0000592) | 2.30171572 |
| 46 | Papilledema (HP:0001085) | 2.24245024 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19690386 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19690386 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19690386 |
| 50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.14922327 |
| 51 | Abnormality of the Achilles tendon (HP:0005109) | 2.14582150 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.14416181 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.11264446 |
| 54 | Orchitis (HP:0100796) | 2.09673266 |
| 55 | Disproportionate tall stature (HP:0001519) | 2.08763921 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.08470606 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.07713748 |
| 58 | Thin bony cortex (HP:0002753) | 2.07145781 |
| 59 | Abnormality of the frontal sinuses (HP:0002687) | 2.06886596 |
| 60 | Recurrent viral infections (HP:0004429) | 2.06814397 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06429375 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.05300247 |
| 63 | Menorrhagia (HP:0000132) | 2.04346701 |
| 64 | Myokymia (HP:0002411) | 2.03957629 |
| 65 | Chronic otitis media (HP:0000389) | 2.03947768 |
| 66 | Mitral regurgitation (HP:0001653) | 2.02720445 |
| 67 | Ulnar bowing (HP:0003031) | 2.01198102 |
| 68 | Persistence of primary teeth (HP:0006335) | 1.99747060 |
| 69 | Syringomyelia (HP:0003396) | 1.99354290 |
| 70 | Spinal cord lesions (HP:0100561) | 1.99354290 |
| 71 | Arterial thrombosis (HP:0004420) | 1.98561215 |
| 72 | Action tremor (HP:0002345) | 1.96652552 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96270694 |
| 74 | Osteolytic defects of the hand bones (HP:0009699) | 1.96270694 |
| 75 | Abnormality of oral frenula (HP:0000190) | 1.95351115 |
| 76 | Pointed chin (HP:0000307) | 1.94805132 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94629528 |
| 78 | Gingivitis (HP:0000230) | 1.94289657 |
| 79 | Shallow orbits (HP:0000586) | 1.93808432 |
| 80 | Difficulty climbing stairs (HP:0003551) | 1.93484597 |
| 81 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.92238697 |
| 82 | Disinhibition (HP:0000734) | 1.91485199 |
| 83 | Inappropriate behavior (HP:0000719) | 1.90876973 |
| 84 | Broad face (HP:0000283) | 1.90767209 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 1.89646016 |
| 86 | Flat acetabular roof (HP:0003180) | 1.88150889 |
| 87 | Subacute progressive viral hepatitis (HP:0006572) | 1.87977435 |
| 88 | Radial bowing (HP:0002986) | 1.87941298 |
| 89 | Atrophic scars (HP:0001075) | 1.86716678 |
| 90 | Increased connective tissue (HP:0009025) | 1.86640976 |
| 91 | Epistaxis (HP:0000421) | 1.85942804 |
| 92 | Elbow flexion contracture (HP:0002987) | 1.85940459 |
| 93 | Bladder diverticulum (HP:0000015) | 1.85718382 |
| 94 | Wormian bones (HP:0002645) | 1.84967222 |
| 95 | Recurrent skin infections (HP:0001581) | 1.84921778 |
| 96 | Bowel diverticulosis (HP:0005222) | 1.83911719 |
| 97 | Spondylolisthesis (HP:0003302) | 1.82783166 |
| 98 | Pulmonary infiltrates (HP:0002113) | 1.82099772 |
| 99 | Long palpebral fissure (HP:0000637) | 1.80522258 |
| 100 | Slender build (HP:0001533) | 1.80413258 |
| 101 | Mitral valve prolapse (HP:0001634) | 1.79752486 |
| 102 | Retrobulbar optic neuritis (HP:0100654) | 1.78927137 |
| 103 | Optic neuritis (HP:0100653) | 1.78927137 |
| 104 | Genu recurvatum (HP:0002816) | 1.78903866 |
| 105 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78838132 |
| 106 | Petechiae (HP:0000967) | 1.76071640 |
| 107 | Hyperacusis (HP:0010780) | 1.75714524 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.75509231 |
| 109 | Prolonged bleeding time (HP:0003010) | 1.75114494 |
| 110 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74932371 |
| 111 | Natal tooth (HP:0000695) | 1.74599110 |
| 112 | Purpura (HP:0000979) | 1.74283780 |
| 113 | Striae distensae (HP:0001065) | 1.74023760 |
| 114 | Joint laxity (HP:0001388) | 1.73279872 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.72368090 |
| 116 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72368090 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 1.72029310 |
| 118 | Periodontitis (HP:0000704) | 1.69902710 |
| 119 | Mutism (HP:0002300) | 1.69411525 |
| 120 | Abnormal platelet function (HP:0011869) | 1.69391538 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.69391538 |
| 122 | Vasculitis (HP:0002633) | 1.68850920 |
| 123 | Aneurysm (HP:0002617) | 1.68667323 |
| 124 | Hemiplegia (HP:0002301) | 1.68247685 |
| 125 | Biconcave vertebral bodies (HP:0004586) | 1.67891818 |
| 126 | Generalized amyotrophy (HP:0003700) | 1.67627772 |
| 127 | Abnormal ossification of hand bones (HP:0005921) | 1.67428985 |
| 128 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.66433658 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.65897111 |
| 130 | Abnormality of the acetabulum (HP:0003170) | 1.65059673 |
| 131 | Type 1 muscle fiber predominance (HP:0003803) | 1.63890862 |
| 132 | Scapular winging (HP:0003691) | 1.63833632 |
| 133 | Abnormality of T cell number (HP:0011839) | 1.63718802 |
| 134 | Abnormality of dentin (HP:0010299) | 1.63534132 |
| 135 | Recurrent bronchitis (HP:0002837) | 1.62949433 |
| 136 | Palpebral edema (HP:0100540) | 1.62781097 |
| 137 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.62062700 |
| 138 | Polycythemia (HP:0001901) | 1.60326066 |
| 139 | Mitral stenosis (HP:0001718) | 1.60238677 |
| 140 | Osteomyelitis (HP:0002754) | 1.59295339 |
| 141 | Thrombocytosis (HP:0001894) | 1.59106203 |
| 142 | Stomatitis (HP:0010280) | 1.58845959 |
| 143 | Loss of speech (HP:0002371) | 1.58363449 |
| 144 | Bicuspid aortic valve (HP:0001647) | 1.58234906 |
| 145 | Soft skin (HP:0000977) | 1.58008224 |
| 146 | Hypercortisolism (HP:0001578) | 1.57890388 |
| 147 | Emphysema (HP:0002097) | 1.57864425 |
| 148 | Bone pain (HP:0002653) | 1.57856747 |
| 149 | Gastrointestinal dysmotility (HP:0002579) | 1.57694438 |
| 150 | Focal seizures (HP:0007359) | 1.57676509 |
| 151 | Chronic obstructive pulmonary disease (HP:0006510) | 1.56882027 |
| 152 | Obstructive lung disease (HP:0006536) | 1.56882027 |
| 153 | Axonal loss (HP:0003447) | 1.56109730 |
| 154 | Trismus (HP:0000211) | 1.56072090 |
| 155 | Ankyloglossia (HP:0010296) | 1.55333310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.26787098 |
| 2 | PRPF4B | 3.16034420 |
| 3 | NTRK1 | 2.85914177 |
| 4 | SMG1 | 2.73101198 |
| 5 | IRAK3 | 2.67541872 |
| 6 | TESK1 | 2.66229990 |
| 7 | TTN | 2.59859426 |
| 8 | RIPK1 | 2.55505452 |
| 9 | SCYL2 | 2.40789445 |
| 10 | MAP3K9 | 2.32006209 |
| 11 | TRIB3 | 2.20643445 |
| 12 | MAP4K1 | 2.09904570 |
| 13 | MAP3K14 | 2.03461632 |
| 14 | TBK1 | 1.95476366 |
| 15 | PKN2 | 1.91501206 |
| 16 | PAK4 | 1.91443085 |
| 17 | MAP2K3 | 1.85906203 |
| 18 | JAK3 | 1.78975483 |
| 19 | TAOK1 | 1.74324877 |
| 20 | EPHA2 | 1.73891934 |
| 21 | TAOK2 | 1.72823332 |
| 22 | TESK2 | 1.71337502 |
| 23 | ICK | 1.71152660 |
| 24 | CAMKK1 | 1.66705704 |
| 25 | SIK1 | 1.66498580 |
| 26 | PAK6 | 1.65114352 |
| 27 | BLK | 1.64724737 |
| 28 | MYLK | 1.61615591 |
| 29 | LIMK1 | 1.58144189 |
| 30 | MAP3K3 | 1.56566846 |
| 31 | JAK1 | 1.52820709 |
| 32 | CDK12 | 1.51258177 |
| 33 | MAP3K13 | 1.50427766 |
| 34 | TYK2 | 1.50418705 |
| 35 | MINK1 | 1.45738056 |
| 36 | NME2 | 1.42097944 |
| 37 | LRRK2 | 1.41157584 |
| 38 | KIT | 1.38214249 |
| 39 | STK10 | 1.32468471 |
| 40 | BMX | 1.32391237 |
| 41 | DMPK | 1.31512559 |
| 42 | LATS2 | 1.30056633 |
| 43 | NTRK2 | 1.27767127 |
| 44 | FES | 1.25337347 |
| 45 | EPHA3 | 1.23319925 |
| 46 | ALK | 1.20371721 |
| 47 | TRPM7 | 1.16947349 |
| 48 | HCK | 1.16753854 |
| 49 | EPHA4 | 1.16538382 |
| 50 | CDC42BPA | 1.13884242 |
| 51 | CSF1R | 1.12239942 |
| 52 | ZAP70 | 1.11117962 |
| 53 | MST1R | 1.08510755 |
| 54 | ERBB3 | 1.07016971 |
| 55 | IKBKE | 1.07005534 |
| 56 | EEF2K | 1.02582262 |
| 57 | KSR2 | 1.01848808 |
| 58 | ILK | 1.01039950 |
| 59 | ITK | 0.99640043 |
| 60 | CAMKK2 | 0.99450760 |
| 61 | LMTK2 | 0.98357733 |
| 62 | RPS6KA4 | 0.98331577 |
| 63 | MAP3K11 | 0.98001258 |
| 64 | FGFR3 | 0.96674414 |
| 65 | SIK2 | 0.95656166 |
| 66 | BMPR2 | 0.95264612 |
| 67 | PTK6 | 0.94749724 |
| 68 | MAP3K8 | 0.93676865 |
| 69 | PRKD2 | 0.93539495 |
| 70 | IRAK4 | 0.93474059 |
| 71 | IKBKB | 0.91744314 |
| 72 | MAP3K1 | 0.89551822 |
| 73 | PAK3 | 0.88136986 |
| 74 | SYK | 0.86430014 |
| 75 | PDGFRA | 0.86072712 |
| 76 | ROCK1 | 0.82962140 |
| 77 | TXK | 0.82858578 |
| 78 | PTK2B | 0.82085952 |
| 79 | TGFBR2 | 0.81413396 |
| 80 | RET | 0.81127186 |
| 81 | SIK3 | 0.79680139 |
| 82 | PLK2 | 0.79333587 |
| 83 | CSK | 0.78912996 |
| 84 | PRKG2 | 0.78101146 |
| 85 | FYN | 0.77608638 |
| 86 | DAPK3 | 0.77572715 |
| 87 | DDR2 | 0.76848195 |
| 88 | CDK5 | 0.76282496 |
| 89 | RPS6KA2 | 0.76086514 |
| 90 | PTK2 | 0.75048530 |
| 91 | PIM2 | 0.74755186 |
| 92 | PDGFRB | 0.73237631 |
| 93 | PRKCH | 0.71963639 |
| 94 | FGR | 0.71515126 |
| 95 | NTRK3 | 0.70220950 |
| 96 | RAF1 | 0.69135485 |
| 97 | LCK | 0.69054353 |
| 98 | DAPK2 | 0.68622461 |
| 99 | MAP3K6 | 0.67687610 |
| 100 | CDK6 | 0.67159395 |
| 101 | MTOR | 0.66485582 |
| 102 | MET | 0.66221515 |
| 103 | DAPK1 | 0.63583242 |
| 104 | KDR | 0.63069227 |
| 105 | PDPK1 | 0.62000340 |
| 106 | ERBB4 | 0.61831150 |
| 107 | MOS | 0.61605287 |
| 108 | NEK9 | 0.61267831 |
| 109 | FRK | 0.60676069 |
| 110 | EPHB1 | 0.58557295 |
| 111 | ARAF | 0.58321360 |
| 112 | STK38 | 0.55801727 |
| 113 | ERN1 | 0.55484101 |
| 114 | EGFR | 0.54852855 |
| 115 | MAP3K10 | 0.54807846 |
| 116 | EPHB2 | 0.54523944 |
| 117 | PAK2 | 0.53683219 |
| 118 | FGFR4 | 0.53435253 |
| 119 | MAP2K1 | 0.53100624 |
| 120 | MAPKAPK2 | 0.52021519 |
| 121 | PDK1 | 0.51740326 |
| 122 | PAK1 | 0.51490222 |
| 123 | MELK | 0.51305327 |
| 124 | ROCK2 | 0.50531293 |
| 125 | PRKCQ | 0.50310861 |
| 126 | BTK | 0.49946456 |
| 127 | MARK3 | 0.49914323 |
| 128 | GRK6 | 0.49841049 |
| 129 | CLK1 | 0.49753114 |
| 130 | SRC | 0.48810800 |
| 131 | INSR | 0.48031478 |
| 132 | TEC | 0.47650578 |
| 133 | RPS6KC1 | 0.47384093 |
| 134 | RPS6KL1 | 0.47384093 |
| 135 | LYN | 0.47364539 |
| 136 | PRKCD | 0.46909762 |
| 137 | MARK1 | 0.46600393 |
| 138 | KSR1 | 0.46570995 |
| 139 | MAPK11 | 0.45969469 |
| 140 | JAK2 | 0.45708259 |
| 141 | CDK4 | 0.43496407 |
| 142 | PIK3CG | 0.37497109 |
| 143 | HIPK2 | 0.36712853 |
| 144 | MARK2 | 0.36615967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15231630 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09675175 |
| 3 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.89298152 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86252018 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.79390021 |
| 6 | Bladder cancer_Homo sapiens_hsa05219 | 1.69222323 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61598960 |
| 8 | Salmonella infection_Homo sapiens_hsa05132 | 1.57288866 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49421642 |
| 10 | Shigellosis_Homo sapiens_hsa05131 | 1.47925564 |
| 11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.43107918 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42250479 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40765998 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.37904244 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37082656 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36642882 |
| 17 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.35961614 |
| 18 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31553016 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31485500 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30675311 |
| 21 | Glioma_Homo sapiens_hsa05214 | 1.29855374 |
| 22 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.28117830 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24390452 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23533332 |
| 25 | Platelet activation_Homo sapiens_hsa04611 | 1.23104349 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22459016 |
| 27 | Thyroid cancer_Homo sapiens_hsa05216 | 1.21982525 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.21248818 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20527971 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20433891 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20421819 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18940248 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18620490 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.17800832 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17274387 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.17006864 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15622923 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15101677 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14582740 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10636149 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.10283059 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.09735820 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.09535923 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08472964 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.08084813 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.05842527 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05458420 |
| 48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04992361 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.04324182 |
| 50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.02875259 |
| 51 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.02155495 |
| 52 | Malaria_Homo sapiens_hsa05144 | 1.01317545 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01293739 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.00172202 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 1.00007825 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99300299 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98475389 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96680007 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96534725 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95997099 |
| 61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95512893 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94940076 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.94550028 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.94345307 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.93606337 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92791262 |
| 67 | Adherens junction_Homo sapiens_hsa04520 | 0.92554756 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92533136 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.91869277 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91415303 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.89634661 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89618038 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87890073 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87856340 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87655019 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87537202 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87087523 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86740537 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86349344 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.84840298 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82383207 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81957413 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81511114 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81046824 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80108680 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80048008 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79986726 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79717031 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79310280 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79045088 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78561301 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78294352 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78069629 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77931025 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77781903 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77092239 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76546793 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76284391 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76191142 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75473783 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75425271 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75225686 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.74220165 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73753618 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73430395 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72607803 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72589035 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72413941 |
| 109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72383452 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72025063 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71575871 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70611345 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69096595 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68564332 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67909332 |
| 116 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67867338 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67667670 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67485616 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67455370 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67336506 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67248454 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66222676 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62321713 |
| 124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61741034 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55177389 |
| 126 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53476536 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53075903 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50765931 |

